nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—SLC51A—osteoporosis	0.336	0.842	CbGaD
Dinoprostone—SLC51B—Conjugated Estrogens—osteoporosis	0.0736	0.164	CbGbCtD
Dinoprostone—SLC51A—Conjugated Estrogens—osteoporosis	0.0736	0.164	CbGbCtD
Dinoprostone—CYP19A1—osteoporosis	0.0633	0.158	CbGaD
Dinoprostone—SLCO3A1—Conjugated Estrogens—osteoporosis	0.0336	0.0748	CbGbCtD
Dinoprostone—SLCO4A1—Conjugated Estrogens—osteoporosis	0.0306	0.068	CbGbCtD
Dinoprostone—SLCO4A1—Estradiol—osteoporosis	0.0268	0.0597	CbGbCtD
Dinoprostone—CYP11A1—Cholecalciferol—osteoporosis	0.0221	0.0492	CbGbCtD
Dinoprostone—SLCO1C1—Conjugated Estrogens—osteoporosis	0.0215	0.0478	CbGbCtD
Dinoprostone—SLCO1C1—Estradiol—osteoporosis	0.0188	0.0419	CbGbCtD
Dinoprostone—SLC22A1—Estropipate—osteoporosis	0.0138	0.0307	CbGbCtD
Dinoprostone—SLCO2B1—Conjugated Estrogens—osteoporosis	0.0135	0.03	CbGbCtD
Dinoprostone—CYP19A1—Raloxifene—osteoporosis	0.0133	0.0297	CbGbCtD
Dinoprostone—SLCO2B1—Estradiol—osteoporosis	0.0118	0.0264	CbGbCtD
Dinoprostone—SLC22A11—Conjugated Estrogens—osteoporosis	0.0111	0.0247	CbGbCtD
Dinoprostone—ABCC4—Conjugated Estrogens—osteoporosis	0.0103	0.023	CbGbCtD
Dinoprostone—SLC22A11—Estradiol—osteoporosis	0.00973	0.0217	CbGbCtD
Dinoprostone—SLCO1A2—Conjugated Estrogens—osteoporosis	0.0074	0.0165	CbGbCtD
Dinoprostone—SLCO1B1—Conjugated Estrogens—osteoporosis	0.00698	0.0155	CbGbCtD
Dinoprostone—SLC22A2—Estradiol—osteoporosis	0.0066	0.0147	CbGbCtD
Dinoprostone—SLCO1A2—Estradiol—osteoporosis	0.0065	0.0145	CbGbCtD
Dinoprostone—SLC22A8—Conjugated Estrogens—osteoporosis	0.00644	0.0143	CbGbCtD
Dinoprostone—SLCO1B1—Estradiol—osteoporosis	0.00613	0.0136	CbGbCtD
Dinoprostone—SLC22A1—Estradiol—osteoporosis	0.00573	0.0128	CbGbCtD
Dinoprostone—SLC22A8—Estradiol—osteoporosis	0.00566	0.0126	CbGbCtD
Dinoprostone—CYP1A2—Estropipate—osteoporosis	0.00483	0.0108	CbGbCtD
Dinoprostone—SLC22A6—Conjugated Estrogens—osteoporosis	0.00449	0.00999	CbGbCtD
Dinoprostone—CYP1A2—Conjugated Estrogens—osteoporosis	0.00229	0.00509	CbGbCtD
Dinoprostone—CYP1A2—Estradiol—osteoporosis	0.00201	0.00447	CbGbCtD
Dinoprostone—Paraesthesia—Estropipate—osteoporosis	0.000132	0.00145	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000131	0.00145	CcSEcCtD
Dinoprostone—Flushing—Zoledronate—osteoporosis	0.000131	0.00145	CcSEcCtD
Dinoprostone—Back pain—Pamidronate—osteoporosis	0.00013	0.00144	CcSEcCtD
Dinoprostone—Muscle spasms—Pamidronate—osteoporosis	0.00013	0.00143	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000129	0.00142	CcSEcCtD
Dinoprostone—Angiopathy—Zoledronate—osteoporosis	0.000128	0.00141	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000128	0.00141	CcSEcCtD
Dinoprostone—Immune system disorder—Zoledronate—osteoporosis	0.000128	0.00141	CcSEcCtD
Dinoprostone—Syncope—Risedronate—osteoporosis	0.000127	0.0014	CcSEcCtD
Dinoprostone—Chills—Zoledronate—osteoporosis	0.000127	0.0014	CcSEcCtD
Dinoprostone—Cough—Ethinyl Estradiol—osteoporosis	0.000127	0.0014	CcSEcCtD
Dinoprostone—Arrhythmia—Zoledronate—osteoporosis	0.000126	0.00139	CcSEcCtD
Dinoprostone—Paraesthesia—Ibandronate—osteoporosis	0.000126	0.00139	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000125	0.00138	CcSEcCtD
Dinoprostone—Pain—Estropipate—osteoporosis	0.000125	0.00138	CcSEcCtD
Dinoprostone—Hypersensitivity—Etidronic acid—osteoporosis	0.000125	0.00137	CcSEcCtD
Dinoprostone—Loss of consciousness—Risedronate—osteoporosis	0.000125	0.00137	CcSEcCtD
Dinoprostone—Cough—Risedronate—osteoporosis	0.000124	0.00136	CcSEcCtD
Dinoprostone—Angiopathy—Conjugated Estrogens—osteoporosis	0.000124	0.00136	CcSEcCtD
Dinoprostone—Pain—Alendronate—osteoporosis	0.000123	0.00136	CcSEcCtD
Dinoprostone—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000123	0.00135	CcSEcCtD
Dinoprostone—Hypertension—Risedronate—osteoporosis	0.000123	0.00135	CcSEcCtD
Dinoprostone—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000122	0.00134	CcSEcCtD
Dinoprostone—Pain—Raloxifene—osteoporosis	0.000121	0.00134	CcSEcCtD
Dinoprostone—Syncope—Pamidronate—osteoporosis	0.000121	0.00133	CcSEcCtD
Dinoprostone—Chest pain—Risedronate—osteoporosis	0.000121	0.00133	CcSEcCtD
Dinoprostone—Arthralgia—Risedronate—osteoporosis	0.000121	0.00133	CcSEcCtD
Dinoprostone—Myalgia—Risedronate—osteoporosis	0.000121	0.00133	CcSEcCtD
Dinoprostone—Pain—Ibandronate—osteoporosis	0.00012	0.00132	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Estropipate—osteoporosis	0.00012	0.00132	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Estradiol—osteoporosis	0.00012	0.00132	CcSEcCtD
Dinoprostone—Back pain—Zoledronate—osteoporosis	0.000119	0.00131	CcSEcCtD
Dinoprostone—Myocardial infarction—Estradiol—osteoporosis	0.000119	0.00131	CcSEcCtD
Dinoprostone—Loss of consciousness—Pamidronate—osteoporosis	0.000119	0.0013	CcSEcCtD
Dinoprostone—Muscle spasms—Zoledronate—osteoporosis	0.000118	0.0013	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Alendronate—osteoporosis	0.000118	0.0013	CcSEcCtD
Dinoprostone—Cough—Pamidronate—osteoporosis	0.000118	0.0013	CcSEcCtD
Dinoprostone—Pain—Calcitriol—osteoporosis	0.000118	0.00129	CcSEcCtD
Dinoprostone—Hypertension—Pamidronate—osteoporosis	0.000116	0.00128	CcSEcCtD
Dinoprostone—Tension—Conjugated Estrogens—osteoporosis	0.000116	0.00128	CcSEcCtD
Dinoprostone—Vision blurred—Zoledronate—osteoporosis	0.000116	0.00128	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Raloxifene—osteoporosis	0.000116	0.00128	CcSEcCtD
Dinoprostone—Diarrhoea—Etidronic acid—osteoporosis	0.000116	0.00128	CcSEcCtD
Dinoprostone—Abdominal pain—Estropipate—osteoporosis	0.000116	0.00127	CcSEcCtD
Dinoprostone—Body temperature increased—Estropipate—osteoporosis	0.000116	0.00127	CcSEcCtD
Dinoprostone—Tremor—Zoledronate—osteoporosis	0.000115	0.00127	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Ibandronate—osteoporosis	0.000115	0.00126	CcSEcCtD
Dinoprostone—Myalgia—Pamidronate—osteoporosis	0.000115	0.00126	CcSEcCtD
Dinoprostone—Arthralgia—Pamidronate—osteoporosis	0.000115	0.00126	CcSEcCtD
Dinoprostone—Back pain—Conjugated Estrogens—osteoporosis	0.000115	0.00126	CcSEcCtD
Dinoprostone—Body temperature increased—Alendronate—osteoporosis	0.000114	0.00126	CcSEcCtD
Dinoprostone—Abdominal pain—Alendronate—osteoporosis	0.000114	0.00126	CcSEcCtD
Dinoprostone—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000114	0.00125	CcSEcCtD
Dinoprostone—Shock—Risedronate—osteoporosis	0.000114	0.00125	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Calcitriol—osteoporosis	0.000112	0.00124	CcSEcCtD
Dinoprostone—Abdominal pain—Raloxifene—osteoporosis	0.000112	0.00123	CcSEcCtD
Dinoprostone—Body temperature increased—Raloxifene—osteoporosis	0.000112	0.00123	CcSEcCtD
Dinoprostone—Vision blurred—Conjugated Estrogens—osteoporosis	0.000112	0.00123	CcSEcCtD
Dinoprostone—Abdominal pain—Ibandronate—osteoporosis	0.000111	0.00122	CcSEcCtD
Dinoprostone—Body temperature increased—Ibandronate—osteoporosis	0.000111	0.00122	CcSEcCtD
Dinoprostone—Syncope—Zoledronate—osteoporosis	0.00011	0.00122	CcSEcCtD
Dinoprostone—Anaphylactic shock—Pamidronate—osteoporosis	0.00011	0.00121	CcSEcCtD
Dinoprostone—Body temperature increased—Calcitriol—osteoporosis	0.000109	0.0012	CcSEcCtD
Dinoprostone—Abdominal pain—Calcitriol—osteoporosis	0.000109	0.0012	CcSEcCtD
Dinoprostone—Shock—Pamidronate—osteoporosis	0.000108	0.00119	CcSEcCtD
Dinoprostone—Loss of consciousness—Zoledronate—osteoporosis	0.000108	0.00119	CcSEcCtD
Dinoprostone—Pharyngitis—Estradiol—osteoporosis	0.000108	0.00119	CcSEcCtD
Dinoprostone—Hypersensitivity—Estropipate—osteoporosis	0.000108	0.00119	CcSEcCtD
Dinoprostone—Vomiting—Etidronic acid—osteoporosis	0.000108	0.00118	CcSEcCtD
Dinoprostone—Cough—Zoledronate—osteoporosis	0.000108	0.00118	CcSEcCtD
Dinoprostone—Tachycardia—Pamidronate—osteoporosis	0.000107	0.00118	CcSEcCtD
Dinoprostone—Rash—Etidronic acid—osteoporosis	0.000107	0.00118	CcSEcCtD
Dinoprostone—Dermatitis—Etidronic acid—osteoporosis	0.000107	0.00117	CcSEcCtD
Dinoprostone—Hyperhidrosis—Pamidronate—osteoporosis	0.000106	0.00117	CcSEcCtD
Dinoprostone—Syncope—Conjugated Estrogens—osteoporosis	0.000106	0.00117	CcSEcCtD
Dinoprostone—Hypertension—Zoledronate—osteoporosis	0.000106	0.00117	CcSEcCtD
Dinoprostone—Hypersensitivity—Alendronate—osteoporosis	0.000106	0.00117	CcSEcCtD
Dinoprostone—Headache—Etidronic acid—osteoporosis	0.000106	0.00117	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000106	0.00116	CcSEcCtD
Dinoprostone—Asthenia—Estropipate—osteoporosis	0.000105	0.00116	CcSEcCtD
Dinoprostone—Arthralgia—Zoledronate—osteoporosis	0.000105	0.00115	CcSEcCtD
Dinoprostone—Myalgia—Zoledronate—osteoporosis	0.000105	0.00115	CcSEcCtD
Dinoprostone—Chest pain—Zoledronate—osteoporosis	0.000105	0.00115	CcSEcCtD
Dinoprostone—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000104	0.00115	CcSEcCtD
Dinoprostone—Paraesthesia—Risedronate—osteoporosis	0.000104	0.00114	CcSEcCtD
Dinoprostone—Asthenia—Alendronate—osteoporosis	0.000104	0.00114	CcSEcCtD
Dinoprostone—Hypersensitivity—Ibandronate—osteoporosis	0.000104	0.00114	CcSEcCtD
Dinoprostone—Cough—Conjugated Estrogens—osteoporosis	0.000104	0.00114	CcSEcCtD
Dinoprostone—Dyspnoea—Risedronate—osteoporosis	0.000103	0.00114	CcSEcCtD
Dinoprostone—Hypotension—Pamidronate—osteoporosis	0.000103	0.00113	CcSEcCtD
Dinoprostone—Hypersensitivity—Calcitriol—osteoporosis	0.000101	0.00112	CcSEcCtD
Dinoprostone—Flushing—Estradiol—osteoporosis	0.000101	0.00111	CcSEcCtD
Dinoprostone—Arthralgia—Conjugated Estrogens—osteoporosis	0.000101	0.00111	CcSEcCtD
Dinoprostone—Myalgia—Conjugated Estrogens—osteoporosis	0.000101	0.00111	CcSEcCtD
Dinoprostone—Chest pain—Conjugated Estrogens—osteoporosis	0.000101	0.00111	CcSEcCtD
Dinoprostone—Asthenia—Ibandronate—osteoporosis	0.000101	0.00111	CcSEcCtD
Dinoprostone—Nausea—Etidronic acid—osteoporosis	0.000101	0.00111	CcSEcCtD
Dinoprostone—Anaphylactic shock—Zoledronate—osteoporosis	0.000101	0.00111	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.0001	0.0011	CcSEcCtD
Dinoprostone—Diarrhoea—Estropipate—osteoporosis	0.0001	0.0011	CcSEcCtD
Dinoprostone—Pain—Risedronate—osteoporosis	9.9e-05	0.00109	CcSEcCtD
Dinoprostone—Angiopathy—Estradiol—osteoporosis	9.9e-05	0.00109	CcSEcCtD
Dinoprostone—Shock—Zoledronate—osteoporosis	9.89e-05	0.00109	CcSEcCtD
Dinoprostone—Paraesthesia—Pamidronate—osteoporosis	9.88e-05	0.00109	CcSEcCtD
Dinoprostone—Diarrhoea—Alendronate—osteoporosis	9.87e-05	0.00109	CcSEcCtD
Dinoprostone—Asthenia—Calcitriol—osteoporosis	9.87e-05	0.00109	CcSEcCtD
Dinoprostone—Immune system disorder—Estradiol—osteoporosis	9.85e-05	0.00108	CcSEcCtD
Dinoprostone—Dyspnoea—Pamidronate—osteoporosis	9.81e-05	0.00108	CcSEcCtD
Dinoprostone—Tachycardia—Zoledronate—osteoporosis	9.81e-05	0.00108	CcSEcCtD
Dinoprostone—Chills—Estradiol—osteoporosis	9.79e-05	0.00108	CcSEcCtD
Dinoprostone—Hyperhidrosis—Zoledronate—osteoporosis	9.72e-05	0.00107	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	9.71e-05	0.00107	CcSEcCtD
Dinoprostone—Diarrhoea—Raloxifene—osteoporosis	9.71e-05	0.00107	CcSEcCtD
Dinoprostone—Dizziness—Estropipate—osteoporosis	9.69e-05	0.00107	CcSEcCtD
Dinoprostone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	9.68e-05	0.00107	CcSEcCtD
Dinoprostone—Diarrhoea—Ibandronate—osteoporosis	9.61e-05	0.00106	CcSEcCtD
Dinoprostone—Dizziness—Alendronate—osteoporosis	9.54e-05	0.00105	CcSEcCtD
Dinoprostone—Shock—Conjugated Estrogens—osteoporosis	9.53e-05	0.00105	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Risedronate—osteoporosis	9.47e-05	0.00104	CcSEcCtD
Dinoprostone—Tachycardia—Conjugated Estrogens—osteoporosis	9.45e-05	0.00104	CcSEcCtD
Dinoprostone—Pain—Pamidronate—osteoporosis	9.41e-05	0.00104	CcSEcCtD
Dinoprostone—Diarrhoea—Calcitriol—osteoporosis	9.41e-05	0.00104	CcSEcCtD
Dinoprostone—Hypotension—Zoledronate—osteoporosis	9.4e-05	0.00103	CcSEcCtD
Dinoprostone—Body temperature increased—Ethinyl Estradiol—osteoporosis	9.39e-05	0.00103	CcSEcCtD
Dinoprostone—Abdominal pain—Ethinyl Estradiol—osteoporosis	9.39e-05	0.00103	CcSEcCtD
Dinoprostone—Dizziness—Raloxifene—osteoporosis	9.39e-05	0.00103	CcSEcCtD
Dinoprostone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	9.36e-05	0.00103	CcSEcCtD
Dinoprostone—Tension—Estradiol—osteoporosis	9.32e-05	0.00103	CcSEcCtD
Dinoprostone—Vomiting—Estropipate—osteoporosis	9.32e-05	0.00103	CcSEcCtD
Dinoprostone—Dizziness—Ibandronate—osteoporosis	9.29e-05	0.00102	CcSEcCtD
Dinoprostone—Rash—Estropipate—osteoporosis	9.24e-05	0.00102	CcSEcCtD
Dinoprostone—Dermatitis—Estropipate—osteoporosis	9.23e-05	0.00102	CcSEcCtD
Dinoprostone—Back pain—Estradiol—osteoporosis	9.18e-05	0.00101	CcSEcCtD
Dinoprostone—Headache—Estropipate—osteoporosis	9.18e-05	0.00101	CcSEcCtD
Dinoprostone—Vomiting—Alendronate—osteoporosis	9.18e-05	0.00101	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Zoledronate—osteoporosis	9.16e-05	0.00101	CcSEcCtD
Dinoprostone—Abdominal pain—Risedronate—osteoporosis	9.15e-05	0.00101	CcSEcCtD
Dinoprostone—Body temperature increased—Risedronate—osteoporosis	9.15e-05	0.00101	CcSEcCtD
Dinoprostone—Muscle spasms—Estradiol—osteoporosis	9.13e-05	0.001	CcSEcCtD
Dinoprostone—Rash—Alendronate—osteoporosis	9.1e-05	0.001	CcSEcCtD
Dinoprostone—Dermatitis—Alendronate—osteoporosis	9.09e-05	0.001	CcSEcCtD
Dinoprostone—Hypotension—Conjugated Estrogens—osteoporosis	9.05e-05	0.000995	CcSEcCtD
Dinoprostone—Headache—Alendronate—osteoporosis	9.04e-05	0.000995	CcSEcCtD
Dinoprostone—Paraesthesia—Zoledronate—osteoporosis	9.03e-05	0.000993	CcSEcCtD
Dinoprostone—Vomiting—Raloxifene—osteoporosis	9.02e-05	0.000993	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Pamidronate—osteoporosis	9e-05	0.00099	CcSEcCtD
Dinoprostone—Dyspnoea—Zoledronate—osteoporosis	8.96e-05	0.000986	CcSEcCtD
Dinoprostone—Rash—Raloxifene—osteoporosis	8.95e-05	0.000985	CcSEcCtD
Dinoprostone—Dermatitis—Raloxifene—osteoporosis	8.94e-05	0.000984	CcSEcCtD
Dinoprostone—Vomiting—Ibandronate—osteoporosis	8.93e-05	0.000983	CcSEcCtD
Dinoprostone—Tremor—Estradiol—osteoporosis	8.9e-05	0.000979	CcSEcCtD
Dinoprostone—Headache—Raloxifene—osteoporosis	8.89e-05	0.000978	CcSEcCtD
Dinoprostone—Rash—Ibandronate—osteoporosis	8.86e-05	0.000975	CcSEcCtD
Dinoprostone—Dermatitis—Ibandronate—osteoporosis	8.85e-05	0.000974	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	8.82e-05	0.000971	CcSEcCtD
Dinoprostone—Headache—Ibandronate—osteoporosis	8.8e-05	0.000969	CcSEcCtD
Dinoprostone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	8.75e-05	0.000963	CcSEcCtD
Dinoprostone—Vomiting—Calcitriol—osteoporosis	8.75e-05	0.000962	CcSEcCtD
Dinoprostone—Nausea—Estropipate—osteoporosis	8.7e-05	0.000958	CcSEcCtD
Dinoprostone—Abdominal pain—Pamidronate—osteoporosis	8.7e-05	0.000958	CcSEcCtD
Dinoprostone—Body temperature increased—Pamidronate—osteoporosis	8.7e-05	0.000958	CcSEcCtD
Dinoprostone—Paraesthesia—Conjugated Estrogens—osteoporosis	8.69e-05	0.000957	CcSEcCtD
Dinoprostone—Rash—Calcitriol—osteoporosis	8.67e-05	0.000954	CcSEcCtD
Dinoprostone—Dermatitis—Calcitriol—osteoporosis	8.66e-05	0.000953	CcSEcCtD
Dinoprostone—Dyspnoea—Conjugated Estrogens—osteoporosis	8.63e-05	0.00095	CcSEcCtD
Dinoprostone—Headache—Calcitriol—osteoporosis	8.62e-05	0.000948	CcSEcCtD
Dinoprostone—Pain—Zoledronate—osteoporosis	8.6e-05	0.000946	CcSEcCtD
Dinoprostone—Nausea—Alendronate—osteoporosis	8.57e-05	0.000943	CcSEcCtD
Dinoprostone—Hypersensitivity—Risedronate—osteoporosis	8.53e-05	0.000939	CcSEcCtD
Dinoprostone—Asthenia—Ethinyl Estradiol—osteoporosis	8.52e-05	0.000938	CcSEcCtD
Dinoprostone—Syncope—Estradiol—osteoporosis	8.51e-05	0.000937	CcSEcCtD
Dinoprostone—Nausea—Raloxifene—osteoporosis	8.43e-05	0.000928	CcSEcCtD
Dinoprostone—Nausea—Ibandronate—osteoporosis	8.35e-05	0.000918	CcSEcCtD
Dinoprostone—Loss of consciousness—Estradiol—osteoporosis	8.35e-05	0.000918	CcSEcCtD
Dinoprostone—Asthenia—Risedronate—osteoporosis	8.31e-05	0.000914	CcSEcCtD
Dinoprostone—Cough—Estradiol—osteoporosis	8.29e-05	0.000912	CcSEcCtD
Dinoprostone—Pain—Conjugated Estrogens—osteoporosis	8.28e-05	0.000911	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Zoledronate—osteoporosis	8.22e-05	0.000905	CcSEcCtD
Dinoprostone—Hypertension—Estradiol—osteoporosis	8.2e-05	0.000902	CcSEcCtD
Dinoprostone—Nausea—Calcitriol—osteoporosis	8.17e-05	0.000899	CcSEcCtD
Dinoprostone—Diarrhoea—Ethinyl Estradiol—osteoporosis	8.13e-05	0.000894	CcSEcCtD
Dinoprostone—Hypersensitivity—Pamidronate—osteoporosis	8.11e-05	0.000892	CcSEcCtD
Dinoprostone—Chest pain—Estradiol—osteoporosis	8.08e-05	0.000889	CcSEcCtD
Dinoprostone—Arthralgia—Estradiol—osteoporosis	8.08e-05	0.000889	CcSEcCtD
Dinoprostone—Myalgia—Estradiol—osteoporosis	8.08e-05	0.000889	CcSEcCtD
Dinoprostone—Abdominal pain—Zoledronate—osteoporosis	7.95e-05	0.000875	CcSEcCtD
Dinoprostone—Body temperature increased—Zoledronate—osteoporosis	7.95e-05	0.000875	CcSEcCtD
Dinoprostone—Diarrhoea—Risedronate—osteoporosis	7.92e-05	0.000872	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	7.92e-05	0.000871	CcSEcCtD
Dinoprostone—Asthenia—Pamidronate—osteoporosis	7.9e-05	0.000869	CcSEcCtD
Dinoprostone—Dizziness—Ethinyl Estradiol—osteoporosis	7.85e-05	0.000864	CcSEcCtD
Dinoprostone—Anaphylactic shock—Estradiol—osteoporosis	7.75e-05	0.000853	CcSEcCtD
Dinoprostone—Dizziness—Risedronate—osteoporosis	7.66e-05	0.000843	CcSEcCtD
Dinoprostone—Abdominal pain—Conjugated Estrogens—osteoporosis	7.65e-05	0.000842	CcSEcCtD
Dinoprostone—Body temperature increased—Conjugated Estrogens—osteoporosis	7.65e-05	0.000842	CcSEcCtD
Dinoprostone—Shock—Estradiol—osteoporosis	7.62e-05	0.000839	CcSEcCtD
Dinoprostone—Tachycardia—Estradiol—osteoporosis	7.56e-05	0.000832	CcSEcCtD
Dinoprostone—Vomiting—Ethinyl Estradiol—osteoporosis	7.55e-05	0.000831	CcSEcCtD
Dinoprostone—Diarrhoea—Pamidronate—osteoporosis	7.53e-05	0.000829	CcSEcCtD
Dinoprostone—Hyperhidrosis—Estradiol—osteoporosis	7.49e-05	0.000824	CcSEcCtD
Dinoprostone—Rash—Ethinyl Estradiol—osteoporosis	7.49e-05	0.000824	CcSEcCtD
Dinoprostone—Dermatitis—Ethinyl Estradiol—osteoporosis	7.48e-05	0.000823	CcSEcCtD
Dinoprostone—Headache—Ethinyl Estradiol—osteoporosis	7.44e-05	0.000819	CcSEcCtD
Dinoprostone—Hypersensitivity—Zoledronate—osteoporosis	7.41e-05	0.000815	CcSEcCtD
Dinoprostone—Vomiting—Risedronate—osteoporosis	7.36e-05	0.00081	CcSEcCtD
Dinoprostone—Rash—Risedronate—osteoporosis	7.3e-05	0.000803	CcSEcCtD
Dinoprostone—Dermatitis—Risedronate—osteoporosis	7.29e-05	0.000803	CcSEcCtD
Dinoprostone—Dizziness—Pamidronate—osteoporosis	7.28e-05	0.000801	CcSEcCtD
Dinoprostone—Headache—Risedronate—osteoporosis	7.25e-05	0.000798	CcSEcCtD
Dinoprostone—Asthenia—Zoledronate—osteoporosis	7.21e-05	0.000794	CcSEcCtD
Dinoprostone—Hypersensitivity—Conjugated Estrogens—osteoporosis	7.13e-05	0.000785	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Estradiol—osteoporosis	7.06e-05	0.000777	CcSEcCtD
Dinoprostone—Nausea—Ethinyl Estradiol—osteoporosis	7.05e-05	0.000776	CcSEcCtD
Dinoprostone—Vomiting—Pamidronate—osteoporosis	7e-05	0.00077	CcSEcCtD
Dinoprostone—Paraesthesia—Estradiol—osteoporosis	6.96e-05	0.000766	CcSEcCtD
Dinoprostone—Asthenia—Conjugated Estrogens—osteoporosis	6.95e-05	0.000764	CcSEcCtD
Dinoprostone—Rash—Pamidronate—osteoporosis	6.94e-05	0.000764	CcSEcCtD
Dinoprostone—Dermatitis—Pamidronate—osteoporosis	6.93e-05	0.000763	CcSEcCtD
Dinoprostone—Dyspnoea—Estradiol—osteoporosis	6.91e-05	0.00076	CcSEcCtD
Dinoprostone—Headache—Pamidronate—osteoporosis	6.9e-05	0.000759	CcSEcCtD
Dinoprostone—Diarrhoea—Zoledronate—osteoporosis	6.88e-05	0.000757	CcSEcCtD
Dinoprostone—Nausea—Risedronate—osteoporosis	6.88e-05	0.000757	CcSEcCtD
Dinoprostone—Dizziness—Zoledronate—osteoporosis	6.65e-05	0.000732	CcSEcCtD
Dinoprostone—Pain—Estradiol—osteoporosis	6.63e-05	0.000729	CcSEcCtD
Dinoprostone—Diarrhoea—Conjugated Estrogens—osteoporosis	6.62e-05	0.000729	CcSEcCtD
Dinoprostone—Nausea—Pamidronate—osteoporosis	6.54e-05	0.000719	CcSEcCtD
Dinoprostone—Dizziness—Conjugated Estrogens—osteoporosis	6.4e-05	0.000704	CcSEcCtD
Dinoprostone—Vomiting—Zoledronate—osteoporosis	6.39e-05	0.000703	CcSEcCtD
Dinoprostone—Rash—Zoledronate—osteoporosis	6.34e-05	0.000698	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Estradiol—osteoporosis	6.34e-05	0.000697	CcSEcCtD
Dinoprostone—Dermatitis—Zoledronate—osteoporosis	6.33e-05	0.000697	CcSEcCtD
Dinoprostone—Headache—Zoledronate—osteoporosis	6.3e-05	0.000693	CcSEcCtD
Dinoprostone—Vomiting—Conjugated Estrogens—osteoporosis	6.16e-05	0.000677	CcSEcCtD
Dinoprostone—Abdominal pain—Estradiol—osteoporosis	6.13e-05	0.000674	CcSEcCtD
Dinoprostone—Body temperature increased—Estradiol—osteoporosis	6.13e-05	0.000674	CcSEcCtD
Dinoprostone—Rash—Conjugated Estrogens—osteoporosis	6.1e-05	0.000672	CcSEcCtD
Dinoprostone—Dermatitis—Conjugated Estrogens—osteoporosis	6.1e-05	0.000671	CcSEcCtD
Dinoprostone—Headache—Conjugated Estrogens—osteoporosis	6.07e-05	0.000667	CcSEcCtD
Dinoprostone—Nausea—Zoledronate—osteoporosis	5.97e-05	0.000657	CcSEcCtD
Dinoprostone—Nausea—Conjugated Estrogens—osteoporosis	5.75e-05	0.000633	CcSEcCtD
Dinoprostone—Hypersensitivity—Estradiol—osteoporosis	5.71e-05	0.000628	CcSEcCtD
Dinoprostone—Asthenia—Estradiol—osteoporosis	5.56e-05	0.000612	CcSEcCtD
Dinoprostone—Diarrhoea—Estradiol—osteoporosis	5.3e-05	0.000583	CcSEcCtD
Dinoprostone—Dizziness—Estradiol—osteoporosis	5.12e-05	0.000564	CcSEcCtD
Dinoprostone—Vomiting—Estradiol—osteoporosis	4.93e-05	0.000542	CcSEcCtD
Dinoprostone—Rash—Estradiol—osteoporosis	4.89e-05	0.000538	CcSEcCtD
Dinoprostone—Dermatitis—Estradiol—osteoporosis	4.88e-05	0.000537	CcSEcCtD
Dinoprostone—Headache—Estradiol—osteoporosis	4.85e-05	0.000534	CcSEcCtD
Dinoprostone—Nausea—Estradiol—osteoporosis	4.6e-05	0.000506	CcSEcCtD
Dinoprostone—ABCC5—Metabolism—PSMA5—osteoporosis	1.18e-05	0.000195	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PSMA2—osteoporosis	1.18e-05	0.000195	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—OXCT1—osteoporosis	1.18e-05	0.000194	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CA2—osteoporosis	1.18e-05	0.000194	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—LEP—osteoporosis	1.17e-05	0.000194	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PSMA5—osteoporosis	1.17e-05	0.000194	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PSMA2—osteoporosis	1.17e-05	0.000194	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CYP27A1—osteoporosis	1.17e-05	0.000193	CbGpPWpGaD
Dinoprostone—ABCC4—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.16e-05	0.000191	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.15e-05	0.00019	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PSMA5—osteoporosis	1.15e-05	0.00019	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PSMA2—osteoporosis	1.15e-05	0.00019	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PSMA2—osteoporosis	1.15e-05	0.00019	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PSMA5—osteoporosis	1.15e-05	0.00019	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—MGLL—osteoporosis	1.15e-05	0.000189	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	1.14e-05	0.000189	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	1.14e-05	0.000189	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ACP5—osteoporosis	1.14e-05	0.000188	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.13e-05	0.000187	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—ADCY5—osteoporosis	1.12e-05	0.000186	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—IDH2—osteoporosis	1.12e-05	0.000186	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.12e-05	0.000186	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.12e-05	0.000186	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—ESR1—osteoporosis	1.12e-05	0.000185	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—POMC—osteoporosis	1.11e-05	0.000184	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.1e-05	0.000182	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CA2—osteoporosis	1.1e-05	0.000181	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—OXCT1—osteoporosis	1.1e-05	0.000181	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CALCA—osteoporosis	1.09e-05	0.00018	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—SPP1—osteoporosis	1.09e-05	0.00018	CbGpPWpGaD
Dinoprostone—SLCO1A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.07e-05	0.000177	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CALCA—osteoporosis	1.07e-05	0.000177	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CALCA—osteoporosis	1.07e-05	0.000177	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—MGLL—osteoporosis	1.07e-05	0.000177	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—POMC—osteoporosis	1.06e-05	0.000176	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—IDH2—osteoporosis	1.06e-05	0.000176	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—TPI1—osteoporosis	1.06e-05	0.000175	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CYP27A1—osteoporosis	1.06e-05	0.000175	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—ENO1—osteoporosis	1.05e-05	0.000173	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IRS1—osteoporosis	1.05e-05	0.000173	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—POMC—osteoporosis	1.04e-05	0.000172	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—POMC—osteoporosis	1.04e-05	0.000172	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—ADCY5—osteoporosis	1.04e-05	0.000172	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PSMA5—osteoporosis	1.03e-05	0.000171	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PSMA2—osteoporosis	1.03e-05	0.000171	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ACP5—osteoporosis	1.03e-05	0.00017	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.01e-05	0.000168	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—POMC—osteoporosis	1.01e-05	0.000167	CbGpPWpGaD
Dinoprostone—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.01e-05	0.000166	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—SPP1—osteoporosis	1e-05	0.000166	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CYP27A1—osteoporosis	9.99e-06	0.000165	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—P4HB—osteoporosis	9.93e-06	0.000164	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—KL—osteoporosis	9.9e-06	0.000164	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IRS2—osteoporosis	9.84e-06	0.000163	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL6R—osteoporosis	9.82e-06	0.000163	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GAPDH—osteoporosis	9.75e-06	0.000161	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—IDH2—osteoporosis	9.74e-06	0.000161	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ACP5—osteoporosis	9.72e-06	0.000161	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—KL—osteoporosis	9.7e-06	0.00016	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—KL—osteoporosis	9.7e-06	0.00016	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IGF1—osteoporosis	9.69e-06	0.00016	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—POMC—osteoporosis	9.66e-06	0.00016	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—LEP—osteoporosis	9.63e-06	0.000159	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	9.59e-06	0.000159	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—CYP19A1—osteoporosis	9.56e-06	0.000158	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—TPI1—osteoporosis	9.55e-06	0.000158	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—TGFB1—osteoporosis	9.5e-06	0.000157	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—RAP1A—osteoporosis	9.5e-06	0.000157	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—POMC—osteoporosis	9.46e-06	0.000156	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—POMC—osteoporosis	9.46e-06	0.000156	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—IGF1—osteoporosis	9.45e-06	0.000156	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL6R—osteoporosis	9.42e-06	0.000156	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—ADCY5—osteoporosis	9.33e-06	0.000154	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL6R—osteoporosis	9.22e-06	0.000153	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL6R—osteoporosis	9.22e-06	0.000153	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—ESR1—osteoporosis	9.19e-06	0.000152	CbGpPWpGaD
Dinoprostone—SLCO1B1—Transmembrane transport of small molecules—ADCY5—osteoporosis	9.15e-06	0.000151	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CYP27A1—osteoporosis	9.15e-06	0.000151	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IRS2—osteoporosis	9.08e-06	0.00015	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—IDH2—osteoporosis	9.07e-06	0.00015	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—TPI1—osteoporosis	9.03e-06	0.000149	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—P4HB—osteoporosis	8.98e-06	0.000149	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	8.96e-06	0.000148	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ACP5—osteoporosis	8.9e-06	0.000147	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—LEP—osteoporosis	8.88e-06	0.000147	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GAPDH—osteoporosis	8.81e-06	0.000146	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IRS1—osteoporosis	8.59e-06	0.000142	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—RAP1A—osteoporosis	8.58e-06	0.000142	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MTHFR—osteoporosis	8.58e-06	0.000142	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CYP27A1—osteoporosis	8.53e-06	0.000141	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—P4HB—osteoporosis	8.49e-06	0.000141	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—ESR1—osteoporosis	8.48e-06	0.00014	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.39e-06	0.000139	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—CYP19A1—osteoporosis	8.37e-06	0.000139	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GAPDH—osteoporosis	8.34e-06	0.000138	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ACP5—osteoporosis	8.3e-06	0.000137	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.28e-06	0.000137	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—TPI1—osteoporosis	8.28e-06	0.000137	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—POMC—osteoporosis	8.27e-06	0.000137	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IRS2—osteoporosis	8.16e-06	0.000135	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—RAP1A—osteoporosis	8.12e-06	0.000134	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL6R—osteoporosis	8.07e-06	0.000133	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IGF1—osteoporosis	7.95e-06	0.000132	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IRS1—osteoporosis	7.93e-06	0.000131	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.82e-06	0.000129	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—ADCY5—osteoporosis	7.81e-06	0.000129	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—P4HB—osteoporosis	7.78e-06	0.000129	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—GPX1—osteoporosis	7.78e-06	0.000129	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ADCY5—osteoporosis	7.76e-06	0.000128	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—TPI1—osteoporosis	7.72e-06	0.000128	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ENO1—osteoporosis	7.68e-06	0.000127	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GAPDH—osteoporosis	7.64e-06	0.000126	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—POMC—osteoporosis	7.63e-06	0.000126	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.62e-06	0.000126	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ADCY5—osteoporosis	7.59e-06	0.000126	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ADCY5—osteoporosis	7.59e-06	0.000126	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PSMA5—osteoporosis	7.56e-06	0.000125	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PSMA2—osteoporosis	7.56e-06	0.000125	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SPP1—osteoporosis	7.51e-06	0.000124	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.48e-06	0.000124	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL6R—osteoporosis	7.45e-06	0.000123	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—RAP1A—osteoporosis	7.44e-06	0.000123	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—IL6—osteoporosis	7.41e-06	0.000123	CbGpPWpGaD
Dinoprostone—CYP1A2—Biological oxidations—POMC—osteoporosis	7.37e-06	0.000122	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SPP1—osteoporosis	7.35e-06	0.000122	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SPP1—osteoporosis	7.35e-06	0.000122	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IGF1—osteoporosis	7.34e-06	0.000121	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—P4HB—osteoporosis	7.25e-06	0.00012	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—MTHFR—osteoporosis	7.18e-06	0.000119	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IRS1—osteoporosis	7.12e-06	0.000118	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GAPDH—osteoporosis	7.12e-06	0.000118	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.08e-06	0.000117	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—FDPS—osteoporosis	6.95e-06	0.000115	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PKM—osteoporosis	6.95e-06	0.000115	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ENO1—osteoporosis	6.94e-06	0.000115	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—RAP1A—osteoporosis	6.94e-06	0.000115	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—ADCY5—osteoporosis	6.84e-06	0.000113	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PSMA5—osteoporosis	6.84e-06	0.000113	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PSMA2—osteoporosis	6.84e-06	0.000113	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—GPX1—osteoporosis	6.82e-06	0.000113	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IRS2—osteoporosis	6.79e-06	0.000112	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IL6R—osteoporosis	6.69e-06	0.000111	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IRS2—osteoporosis	6.64e-06	0.00011	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IRS2—osteoporosis	6.64e-06	0.00011	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—LEP—osteoporosis	6.64e-06	0.00011	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GPD2—osteoporosis	6.59e-06	0.000109	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PGLS—osteoporosis	6.59e-06	0.000109	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ENO1—osteoporosis	6.56e-06	0.000109	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—LEP—osteoporosis	6.5e-06	0.000108	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—LEP—osteoporosis	6.5e-06	0.000108	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PSMA5—osteoporosis	6.47e-06	0.000107	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PSMA2—osteoporosis	6.47e-06	0.000107	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ESR1—osteoporosis	6.34e-06	0.000105	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—MTHFR—osteoporosis	6.29e-06	0.000104	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ESR1—osteoporosis	6.21e-06	0.000103	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ESR1—osteoporosis	6.21e-06	0.000103	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CYP19A1—osteoporosis	6.14e-06	0.000102	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—IL6—osteoporosis	6.08e-06	0.000101	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ATIC—osteoporosis	6.03e-06	9.97e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PNP—osteoporosis	6.03e-06	9.97e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ENO1—osteoporosis	6.02e-06	9.95e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PSMA2—osteoporosis	5.93e-06	9.81e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PSMA5—osteoporosis	5.93e-06	9.81e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IRS1—osteoporosis	5.93e-06	9.81e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MYC—osteoporosis	5.82e-06	9.63e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TGFB1—osteoporosis	5.81e-06	9.61e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IRS1—osteoporosis	5.8e-06	9.6e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IRS1—osteoporosis	5.8e-06	9.6e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—POMC—osteoporosis	5.74e-06	9.51e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—POMC—osteoporosis	5.71e-06	9.44e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TGFB1—osteoporosis	5.66e-06	9.37e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—IL6—osteoporosis	5.61e-06	9.29e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ENO1—osteoporosis	5.61e-06	9.28e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—POMC—osteoporosis	5.59e-06	9.24e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—POMC—osteoporosis	5.59e-06	9.24e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL6R—osteoporosis	5.57e-06	9.21e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PSMA5—osteoporosis	5.52e-06	9.14e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PSMA2—osteoporosis	5.52e-06	9.14e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IGF1—osteoporosis	5.49e-06	9.08e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL6R—osteoporosis	5.45e-06	9.02e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL6R—osteoporosis	5.45e-06	9.02e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IGF1—osteoporosis	5.37e-06	8.89e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IGF1—osteoporosis	5.37e-06	8.89e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CYP19A1—osteoporosis	5.25e-06	8.68e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CA2—osteoporosis	5.12e-06	8.48e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—OXCT1—osteoporosis	5.12e-06	8.48e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—POMC—osteoporosis	5.03e-06	8.33e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ADCY5—osteoporosis	5.01e-06	8.3e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GPX1—osteoporosis	5e-06	8.27e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—MGLL—osteoporosis	4.99e-06	8.26e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CYP19A1—osteoporosis	4.81e-06	7.96e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MYC—osteoporosis	4.78e-06	7.91e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TGFB1—osteoporosis	4.77e-06	7.89e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.71e-06	7.79e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—MTHFR—osteoporosis	4.61e-06	7.63e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ADCY5—osteoporosis	4.53e-06	7.5e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GPX1—osteoporosis	4.52e-06	7.47e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CYP19A1—osteoporosis	4.48e-06	7.42e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MYC—osteoporosis	4.41e-06	7.3e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TGFB1—osteoporosis	4.4e-06	7.28e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL6—osteoporosis	4.38e-06	7.24e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ADCY5—osteoporosis	4.29e-06	7.09e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GPX1—osteoporosis	4.27e-06	7.07e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—IDH2—osteoporosis	4.25e-06	7.03e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL6—osteoporosis	4.2e-06	6.95e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—MTHFR—osteoporosis	4.17e-06	6.9e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL6—osteoporosis	4.11e-06	6.8e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL6—osteoporosis	4.11e-06	6.8e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP27A1—osteoporosis	3.99e-06	6.61e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MYC—osteoporosis	3.97e-06	6.56e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TGFB1—osteoporosis	3.96e-06	6.55e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—MTHFR—osteoporosis	3.94e-06	6.52e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ADCY5—osteoporosis	3.93e-06	6.5e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GPX1—osteoporosis	3.92e-06	6.48e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ACP5—osteoporosis	3.88e-06	6.43e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.83e-06	6.34e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—POMC—osteoporosis	3.69e-06	6.1e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ADCY5—osteoporosis	3.66e-06	6.06e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GPX1—osteoporosis	3.65e-06	6.04e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—MTHFR—osteoporosis	3.61e-06	5.98e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—TPI1—osteoporosis	3.61e-06	5.97e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL6—osteoporosis	3.59e-06	5.95e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—P4HB—osteoporosis	3.39e-06	5.62e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—MTHFR—osteoporosis	3.37e-06	5.57e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—POMC—osteoporosis	3.33e-06	5.51e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GAPDH—osteoporosis	3.33e-06	5.51e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL6—osteoporosis	3.32e-06	5.49e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MYC—osteoporosis	3.3e-06	5.46e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TGFB1—osteoporosis	3.29e-06	5.45e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—RAP1A—osteoporosis	3.25e-06	5.37e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MYC—osteoporosis	3.23e-06	5.34e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MYC—osteoporosis	3.23e-06	5.34e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TGFB1—osteoporosis	3.22e-06	5.33e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TGFB1—osteoporosis	3.22e-06	5.33e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—POMC—osteoporosis	3.15e-06	5.22e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IL6—osteoporosis	2.98e-06	4.93e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—POMC—osteoporosis	2.89e-06	4.78e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.83e-06	4.68e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—POMC—osteoporosis	2.69e-06	4.46e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ENO1—osteoporosis	2.62e-06	4.34e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PSMA5—osteoporosis	2.58e-06	4.28e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PSMA2—osteoporosis	2.58e-06	4.28e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL6—osteoporosis	2.48e-06	4.1e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL6—osteoporosis	2.43e-06	4.02e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL6—osteoporosis	2.43e-06	4.02e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP19A1—osteoporosis	2.1e-06	3.47e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ADCY5—osteoporosis	1.71e-06	2.84e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GPX1—osteoporosis	1.71e-06	2.83e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—MTHFR—osteoporosis	1.58e-06	2.61e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—POMC—osteoporosis	1.26e-06	2.09e-05	CbGpPWpGaD
